We are incredibly honored to have Eric Horvitz join Every Cure's Board of Directors! Eric has been a pioneer in artificial intelligence for decades and will help guide Every Cure in our pursuit of leveraging AI to unlock hidden cures.

Fabulous team that’s making concrete progress on an important & promising mission. Every Cure David Fajgenbaum, MD

I'm super excited to share that Every Cure has just completed its most recent round of hiring! We're now up to over 25 team members with experiences across a variety of industries. Our tech team has members who've been leading AI driven drug discovery for pharmaceutical

1 in 10 of us live with a disease without an approved therapy. Even more frightening is that 50-80% of people with rare diseases are children, 30% of whom will not survive until kindergarten. Repurposing existing drugs for new indications is both faster and less expensive than

One of the leading causes of infertility in women may be treatable with a repurposed drug! PCOS (Polycystic Ovary Syndrome) affects 1 in 10 women, and a drug initially developed for malaria has shown promise in a small clinical trial. Researchers in China identified this

The doctor who deserves the next Nobel Prize created a life-saving drug and even tested it on himself! Kazu Yoshizaki was studying Castleman disease when he developed a drug called tocilizumab. However, the ethics committee in Japan wouldn’t allow him to administer it to

To develop a new drug from scratch, a drug company needs to invest 10 years and a billion dollars. However for every clinical trial that Every Cure embarks on, we're looking at an investment of $1 to $5 million. This dramatic reduction is possible because we're not starting from

Early on in my life I always thought there was “they” looking for cures for all diseases. Unfortunately I was wrong. In my book I call it the Santa Claus theory of civilization: that for every problem in the world, there are surely people working diligently—in workshops near

I first decided I wanted to go into medicine after my mom passed away from a glioblastoma brain tumor. I promised her I would dedicate my life to finding treatments for patients like her. Recently, we came across a study that found that the antidepressant Prozac might be a

At Every Cure, we are pioneering the use of agent-based models to revolutionize drug repurposing. We first rank all 3,000 FDA-approved drugs against 22,000 diseases, generating 66 million scores. After generating initial scores for potential treatments, we are pioneering

We had such a great time sitting down with Nobel Prize winner Dr. Drew Weissman a couple weeks ago at the Every Cure All-Hands Meeting! We discussed everything from drug repurposing to what it’s like to win the Nobel Prize! Check out our full discussion with timestamps below:

I’m going to have an identity crisis! Should I be the LeCount Disease Collaborative Network?!

I feel for you CDCN… Next thing you know, I’ll be called LeEvery Cure!

Did you know that a repurposed drug saved the most promising treatment in all of cancer research? Here’s the untold story of a drug initially approved for Castleman Disease that saved CAR T-cell therapy and a young girl's life. (🧵1/6)

Viagra is one of the best examples of repurposing. It was originally developed for heart-related chest pain before being repurposed for its well-known use. But did you know it's also used to save the lives of children suffering from a rare lung disease? Here's how it works 👇

We are excited to bring you our newest patient documentary, Fourth and Long: Rob Long's Inspiring Battle Against Brain Cancer Click the link below to watch the full documentary! youtube.com/watch?v=hlUbaY…

Imagine you’re getting ready to be drafted into the NFL, when all of a sudden you get diagnosed with a rare form of brain cancer. Even worse, there are no approved treatments in the 5 year survival rate is under 15%. Your only hope is that your doctor can find a treatment

A 100-year-old drug might be a promising treatment for autism spectrum disorder! A small clinical trial recently revealed that Suramin, a drug originally developed for African sleeping sickness, seems to improve communication skills and social behaviors in individuals with

What does Nobel Prize Winner Dr. Drew Weissman think of drug repurposing? Like us, he thinks it’s a no brainer! Developing new treatments for diseases is costly, time-consuming and driven by profit. Novel drug development requires $1-2B and 10-15 years per drug, and has a 90%

When a drug receives FDA approval, its research and development (R&D) often shifts away from further exploration into new indications. It's a common misconception that approval marks the peak of a drug's journey. In reality, it’s the opposite. When the drug eventually turns